Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A half-century of neurotransmitter research: impact on neurology and psychiatry. Nobel lecture.

Literature DB >> 12166820

A half-century of neurotransmitter research: impact on neurology and psychiatry. Nobel lecture.

Abstract

The effect that research on dopamine and other neutro trasmitters has on disciplines like neurology and psychiatry is described.

Entities: Chemical

Mesh：

Substances：
Neurotransmitter Agents

Year: 2001 PMID： 12166820 DOI： 10.1023/a:1015556204669

Source DB: PubMed Journal: Biosci Rep ISSN： 0144-8463 Impact factor: 3.840

Keyword Cloud
Cited

13 in total

1. Techniques for neuropeptide determination.

Authors: Mats Sandberg; Stephen G Weber
Journal: Trends Analyt Chem Date: 2003-09 Impact factor: 12.296

Review 2. A next step in adeno-associated virus-mediated gene therapy for neurological diseases: regulation and targeting.

Authors: Abdelwahed Chtarto; Olivier Bockstael; Terence Tshibangu; Olivier Dewitte; Marc Levivier; Liliane Tenenbaum
Journal: Br J Clin Pharmacol Date: 2013-08 Impact factor: 4.335

3. Distinct temporal phases in the behavioral pharmacology of LSD: dopamine D2 receptor-mediated effects in the rat and implications for psychosis.

Authors: Danuta Marona-Lewicka; Ronald A Thisted; David E Nichols
Journal: Psychopharmacology (Berl) Date: 2005-02-19 Impact factor: 4.530

Review 4. The antipsychotic landscape: dopamine and beyond.

Authors: Paul D Morrison; Robin M Murray
Journal: Ther Adv Psychopharmacol Date: 2018-01-23

5. Noninvasive, neuron-specific gene therapy can be facilitated by focused ultrasound and recombinant adeno-associated virus.

Authors: S Wang; O O Olumolade; T Sun; G Samiotaki; E E Konofagou
Journal: Gene Ther Date: 2014-11-06 Impact factor: 5.250

10. Antipsychotic profile of rolipram: efficacy in rats and reduced sensitivity in mice deficient in the phosphodiesterase-4B (PDE4B) enzyme.

Authors: Judith A Siuciak; Douglas S Chapin; Sheryl A McCarthy; Ashley N Martin
Journal: Psychopharmacology (Berl) Date: 2007-03-02 Impact factor: 4.415

A half-century of neurotransmitter research: impact on neurology and psychiatry. Nobel lecture.

1. Techniques for neuropeptide determination.

Review 2. A next step in adeno-associated virus-mediated gene therapy for neurological diseases: regulation and targeting.

3. Distinct temporal phases in the behavioral pharmacology of LSD: dopamine D2 receptor-mediated effects in the rat and implications for psychosis.

Review 4. The antipsychotic landscape: dopamine and beyond.

5. Noninvasive, neuron-specific gene therapy can be facilitated by focused ultrasound and recombinant adeno-associated virus.

6. CDNF: An innovative actor in disease-modifying approaches for Parkinson's disease.

Review 7. Potential pharmacological treatment of fragile X syndrome during adulthood.

8. Behavioral and neurochemical characterization of mice deficient in the phosphodiesterase-4B (PDE4B) enzyme.

9. Group I mGluR antagonist rescues the deficit of D1-induced LTP in a mouse model of fragile X syndrome.

10. Antipsychotic profile of rolipram: efficacy in rats and reduced sensitivity in mice deficient in the phosphodiesterase-4B (PDE4B) enzyme.